Isoniazid acetylator status of Black South African tuberculosis patients.
作者信息
Bach P H, Higgins-Opitz S B, Bima B, Leary W P
出版信息
S Afr Med J. 1976 Jul 10;50(29):1132-4.
PMID:959925
Abstract
Black male tuberculosis patients (106) were phenotyped into 59% fast and 41% slow acetylators with isoniazid (NH) plasma half-lives. The antimode time dividing the two acetylator groups was longer than that previously reported for Whites. The therapeutic significance of INH acetylator phenotyping per se is questioned since it provides neither a measurement of the amount of INH absorption nor of its distribution within the body.
摘要
相似文献
1
Isoniazid acetylator status of Black South African tuberculosis patients.
S Afr Med J. 1976 Jul 10;50(29):1132-4.
2
Isoniazid disposition, comparison of isoniazid phenotyping methods in and acetylator distribution of Japanese patients with idiopathic systemic lupus erythematosus and control subjects.异烟肼代谢、日本特发性系统性红斑狼疮患者与对照受试者的异烟肼表型分析方法比较及乙酰化酶分布
Br J Clin Pharmacol. 1982 Mar;13(3):361-74. doi: 10.1111/j.1365-2125.1982.tb01387.x.
3
Isoniazid inactivation in Black patients with tuberculosis.黑人肺结核患者中异烟肼的失活情况。
S Afr Med J. 1976 Mar 20;50(12):463-5.
4
Acetylator phenotype and metabolic disposition of isoniazid in Japanese patients with systemic lupus erythematosus.日本系统性红斑狼疮患者的乙酰化表型及异烟肼的代谢情况
Arthritis Rheum. 1981 Oct;24(10):1245-54. doi: 10.1002/art.1780241004.
5
Comparison between serum isonicotinic acid hydrazide (INH) levels and urinary sulfadimidine (sulfamethazine) acetylation as predictors of INH acetylator status.血清异烟肼（INH）水平与尿磺胺二甲嘧啶（磺胺甲嘧啶）乙酰化作为INH乙酰化状态预测指标的比较。
Dev Pharmacol Ther. 1988;11(1):32-6. doi: 10.1159/000457661.
6
Isoniazid pharmacokinetics in children according to acetylator phenotype.
Fundam Clin Pharmacol. 2001 Oct;15(5):355-9. doi: 10.1046/j.1472-8206.2001.00044.x.
7
Is there any difference between acetylator phenotypes in tuberculosis patients and healthy subjects?肺结核患者和健康受试者的乙酰化表型有差异吗？
Eur J Clin Pharmacol. 2010 Mar;66(3):261-7. doi: 10.1007/s00228-009-0745-1.
8
A simple method for determining acetylator phenotype using isoniazid.一种使用异烟肼测定乙酰化酶表型的简单方法。
Br J Clin Pharmacol. 1986 Sep;22(3):343-5. doi: 10.1111/j.1365-2125.1986.tb02897.x.
9
Isoniazid acetylation phenotyping in Saudi Arabs.沙特阿拉伯人的异烟肼乙酰化表型分析
J Clin Pharm Ther. 2004 Oct;29(5):443-7. doi: 10.1111/j.1365-2710.2004.00588.x.
10
Determination of the acetylator phenotype in Moroccan tuberculosis patients using isoniazid as metabolic probe.以异烟肼作为代谢探针测定摩洛哥结核病患者的乙酰化表型。
Int J Clin Pharmacol Ther. 2002 Dec;40(12):548-53. doi: 10.5414/cpp40548.
引用本文的文献
1
-Acetyltransferase 2 Genotypes among Zulu-Speaking South Africans and Isoniazid and -Acetyl-Isoniazid Pharmacokinetics during Antituberculosis Treatment.南非祖鲁语人群中乙酰转移酶 2 基因型与抗结核治疗期间异烟肼和乙酰异烟肼药代动力学的关系。
Antimicrob Agents Chemother. 2020 Mar 24;64(4). doi: 10.1128/AAC.02376-19.
2
Clinical and Molecular Risk Factors of Anti-tubercular Therapy Induced Hepatitis.抗结核治疗所致肝炎的临床及分子危险因素
J Clin Exp Hepatol. 2019 Mar-Apr;9(2):200-206. doi: 10.1016/j.jceh.2018.06.012. Epub 2018 Jun 21.
3
Comparison of CYP1A2 and NAT2 phenotypes between black and white smokers.黑人和白人吸烟者之间CYP1A2和NAT2表型的比较。
Biochem Pharmacol. 2008 Oct 1;76(7):929-37. doi: 10.1016/j.bcp.2008.07.024. Epub 2008 Jul 25.
4
Clinical pharmacokinetics of isoniazid.异烟肼的临床药代动力学
Clin Pharmacokinet. 1979 Nov-Dec;4(6):401-22. doi: 10.2165/00003088-197904060-00001.
Zotero 插件